Presentation

Academic

  • Moderator, GI Oral Scientific Session, ASTRO 55thAnnual Meeting, Boston, MA, 2013 Faculty speaker, Esophagus and Gastric Cancers Refresher Course, ASTRO Educational Session, ASTRO 54th Annual Meeting, Boston, MA, 2012 Faculty Speaker, “Contemporary radiation therapy for hepatobiliary cancer”, Multidisciplinary Cancer Symposium, University of Kansas, Kansas City, MO, 2011 Faculty Speaker, “If technology matters…What is the best way forward?”,  2011 International Symposium on Radiation Medicine: The Future Research and Development of Radiation Medicine, National Taiwan University, Taipei, Taiwan, 2011 Faculty speaker, Esophagus and Gastric Cancers Refresher Course, ASTRO Educational Session, ASTRO 53rd Annual Meeting, Miami, FL, 2011 Faculty speaker, “Benefits and challenges of radiation therapy in gastric cancer”, International Gastric Cancer Congress (IGCC), Seoul, Korea, 2011 Faculty speaker, GI Cancer Refresher Course, Sino-American Network for Therapeutic Radiology and Oncology (SANTRO), 3rd Annual Meeting, Hangzhou, China, 2010 Faculty speaker, Esophagus Cancer Refresher Course, ASTRO Educational Session, ASTRO 52nd Annual Meeting, San Diego, CA, 2010 Visiting Professor, “Esophageal Cancer~ A Tough Pill to Swallow”, Case Western University, Cleveland, OH, 2010 Visiting Professor, “Esophageal Cancer~ A Tough Pill to Swallow”, Cedars-Sina Medical Center, Los Angeles, CA, 2010 Visiting Professor, “Esophageal Cancer~ A Tough Pill to Swallow”, Fox Chase Cancer Center, Philadelphia, PA, 2010 Visiting Professor, “Esophageal Cancer~ A Tough Pill to Swallow”, University of Florida, Jacksonville, FL, 2010 Medical Grand Round Speaker, “Esophageal Cancer~ A Tough Pill to Swallow”, Roswell Park Cancer Institute, Buffalo, NY, 2010 Faculty speaker, Esophagus Cancer Refresher Course, ASTRO Educational Session, ASTRO 51st Annual Meeting, Chicago, IL, 2009 Panel Discussant, “Management of esophageal and gastric cancers”. International Society of GI Oncology (ISGIO) Annual Meeting, Philadelphia, PA, 2009 Moderator, GI Scientific Session, ASTRO 50th Annual Meeting, Boston, MA, 2008 Faculty speaker, “Principles of modern radiation techniques for esophageal and gastroesophageal cancers”. International Society of GI Oncology (ISGIO) Annual Meeting, Arlington, VA, 2008 Panel Discussant, “Management of esophageal and gastric cancers”. International Society of GI Oncology (ISGIO) Annual Meeting, Arlington, VA, 2008 Discussant, GI Scientific Session, ASTRO 49th Annual Meeting, Los Angeles, CA, 2007 Visiting professor, “US radiation oncology residency programs”, Department of Radiation Oncology, University of Vienna, Vienna, Austria, 2004. Speaker, “Development of a new HSP-110/Her-2/neu vaccine trial for breast and ovarian cancer.” The 7th Annual Regional Cancer Center Consortium for the Biological Therapy of Cancer: Back to the Future! Buffalo, New York, 2004. Visiting professor, “Radiation oncology training in US”, Department of Radiation Oncology, National Yang-ming University, Taipei, Taiwan, 2004. (09/2010)

Other

  • National Media Interviews: Bonus: for anal cancer patients, “dose-painted” IMRT = better quality of life, Physicians Practice, Jan 2010 “On residency applications, some fudge the details”, Reuters Health, July 2010 “Phase III trial of adjuvant capecitabine/cisplatin vs capecitabine/cisplatin/RT in resected gastric cancer with D2 nodal dissection (ARTIST trial): safety analysis” ASTRO/ASCO GI Cancer Symposium, San Francisco, HemOnc Today, Jan 2009 “Final safety findings from a randomized phase III trial of preoperative FU-based chemoradiation +/- weekly oxaliplatin as neoadjuvant therapy for patients with locally advanced rectal cancer: The STAR (Studio Terapia Adiuvante Retto)-01 randomized trial”, ASTRO/ASCO GI Cancer Symposium, San Francisco, HemOnc Today, Jan 2009 “DNA vaccination controls Her-2+ tumors that are refractory to targeted therapies”, Cancer Research, 68:7502-7511, WebMD Health News, Sept 2008 “Abdominal radiation may affect kidneys”, ASTRO Annual Meeting, Boston, Renal and Urology News, Sept 2008 “A Phase II study of cetuximab (C225) combination with chemoradiation in patients with stage IIIA/B non-small cell lung cancer: A report of the 2 year and median survival for the RTOG 0324 trial”, ASTRO/ASCO Thoracic Cancer Symposium, Chicago, HemOnc Today, Sept 2008 “Proton therapy with concurrent chemotherapy can reduce toxicity and allow higher radiation doses in advanced non-small cell lung cancer”, ASTRO/ASCO Thoracic Cancer Symposium, Chicago, HemOnc Today, Sept  2008 “Analysis of V20 and radiation pneumonitis on SWOG 0023: A phase III trial of concurrent chemoradiation and docetaxel consolidation followed by gefitinib or placebo in stage III non-small cell lung cancer”, ASTRO/ASCO Thoracic Cancer Symposium, Chicago, HemOnc Today, Sept 2008 (Present)